Market Cap
$132.58B
$367.98B
Country
United States
United States
Employees
88.00K
131.90K
Industry
🇺🇸 United States
🇺🇸 United States
Outstanding Shares
5.69B
2.41B
Comparison Verdict
About Pfizer and Johnson & Johnson
Pfizer (PFE) and Johnson & Johnson (JNJ) are both prominent companies in their respective sectors. This comparison helps investors understand the key differences between these two stocks.
Key Takeaways
- Market Cap: Pfizer ($132.58B) vs Johnson & Johnson ($367.98B)
- Valuation: Pfizer has a P/E ratio of $16.76 vs $16.87 for Johnson & Johnson
- Dividend Yield: Pfizer offers 7.30% vs 2.43% from Johnson & Johnson
- Assets: Pfizer has $213.40B in total assets compared to $193.67B for Johnson & Johnson
- 1-Year Performance: Pfizer gained 0.23% vs gain of 1.53% for Johnson & Johnson
- Outstanding Shares: Pfizer has 5.69B shares vs 2.41B for Johnson & Johnson